132 related articles for article (PubMed ID: 1310219)
21. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.
Gomez-Sanchez EP; Gomez-Sanchez CE
Am J Physiol; 1992 Dec; 263(6):E1125-30. PubMed ID: 1476186
[TBL] [Abstract][Full Text] [Related]
22. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
[TBL] [Abstract][Full Text] [Related]
23. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
[TBL] [Abstract][Full Text] [Related]
24. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
[TBL] [Abstract][Full Text] [Related]
25. 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and salt-resistant (R/JR) Dahl rats.
Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 1988 Mar; 122(3):1110-3. PubMed ID: 3342746
[TBL] [Abstract][Full Text] [Related]
26. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
[TBL] [Abstract][Full Text] [Related]
27. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
Gabor A; Leenen FH
Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular infusion of aldosterone induces hypertension in rats.
Gomez-Sanchez EP
Endocrinology; 1986 Feb; 118(2):819-23. PubMed ID: 3943493
[TBL] [Abstract][Full Text] [Related]
29. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid receptors and hypertension.
Funder JW
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):53-5. PubMed ID: 7626506
[TBL] [Abstract][Full Text] [Related]
31. Effect of naloxone on hypertension in Dahl salt-sensitive rats.
Johnson MD; Richmond BK
Am J Physiol; 1992 Jan; 262(1 Pt 2):H162-7. PubMed ID: 1733307
[TBL] [Abstract][Full Text] [Related]
32. Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension.
Gomez-Sanchez EP; Gomez-Sanchez CM; Plonczynski M; Gomez-Sanchez CE
Exp Physiol; 2010 Jan; 95(1):120-30. PubMed ID: 19837774
[TBL] [Abstract][Full Text] [Related]
33. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
35. Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats.
Mukai H; Fitzgibbon WR; Ploth DW; Margolius HS
Br J Pharmacol; 1998 May; 124(1):197-205. PubMed ID: 9630360
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.
Nariai T; Fujita K; Mori M; Katayama S; Hori S; Matsui K
Pharmacology; 2012; 89(1-2):44-52. PubMed ID: 22302095
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 1999 Dec; 385(2-3):199-202. PubMed ID: 10607876
[TBL] [Abstract][Full Text] [Related]
38. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats.
Rapp JP; Dene H
Hypertension; 1985; 7(3 Pt 1):340-9. PubMed ID: 3997219
[TBL] [Abstract][Full Text] [Related]
39. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Nakano M; Hirooka Y; Matsukawa R; Ito K; Sunagawa K
Hypertens Res; 2013 Mar; 36(3):277-84. PubMed ID: 23096235
[TBL] [Abstract][Full Text] [Related]
40. Effect of dietary tryptophan on the development of hypertension in the Dahl salt-sensitive rat.
Lark LA; Witt PA; Becker KB; Studzinski WM; Weyhenmeyer JA
Clin Exp Hypertens A; 1990; 12(1):1-13. PubMed ID: 2137737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
